![Klaus Giese](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Klaus Giese
Chief Executive Officer at Pantherna Therapeutics GmbH
Klaus Giese active positions
Companies | Position | Start | End |
---|---|---|---|
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Chief Tech/Sci/R&D Officer | 1998-12-31 | - |
Pantherna Therapeutics GmbH
![]() Pantherna Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Pantherna Therapeutics GmbH enages in developing of therapeutics for vascular diseases. The company is headquartered in Hennigsdorf, Germany. | Chief Executive Officer | 2016-12-31 | - |
Career history of Klaus Giese
Former positions of Klaus Giese
Companies | Position | Start | End |
---|---|---|---|
SILENCE THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2010-11-22 | 2013-11-17 |
Chiron Corp.
![]() Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 1993-12-31 | 1997-12-31 |
Max-Planck-Institute for Molecular Genetics | Chief Tech/Sci/R&D Officer | - | - |
Howard Hughes Medical Institute, Inc.
![]() Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Chief Tech/Sci/R&D Officer | - | - |
Training of Klaus Giese
Freie Universität Berlin | Doctorate Degree |
Statistics
International
Germany | 5 |
United States | 3 |
United Kingdom | 2 |
Operational
Chief Tech/Sci/R&D Officer | 4 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SILENCE THERAPEUTICS PLC | Commercial Services |
Private companies | 4 |
---|---|
Chiron Corp.
![]() Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Howard Hughes Medical Institute, Inc.
![]() Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Miscellaneous |
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Health Technology |
Pantherna Therapeutics GmbH
![]() Pantherna Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Pantherna Therapeutics GmbH enages in developing of therapeutics for vascular diseases. The company is headquartered in Hennigsdorf, Germany. | Health Technology |
- Stock Market
- Insiders
- Klaus Giese
- Experience